American Society of Hematology Selects 31 Medical Students and Residents for 2018 HONORS Award

American Society of Hematology's picture

Published on: October 02, 2018

(WASHINGTON, October 2, 2018) – The American Society of Hematology (ASH) announced the names of 17 medical students and 14 residents selected to receive the 2018 Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award.

The ASH HONORS Award aims to support talented North American medical students and residents who are interested in hematology but have not yet entered a hematology-related training program. Recipients receive a stipend of $5,000 to conduct hematology research projects either in the short-term (up to three months) or flexibly over a longer-term (between three and 12 months) and $1,000 each year for two years to support their attendance at the ASH annual meeting. Each HONORS participant will have an ASH member research mentor who will assist and oversee the awardee’s work and progress.

The 2018 ASH HONORS Award recipients are:

Medical Students:

Recipients Research Topics
Jihad Aljabban, AB, MMSc
Ohio State University Hospital
Columbus, OH
Investigating the role of IFNy and TNFa in driving multiple myeloma pathogenesis
Kelsey Busken, MSc
University of Missouri
Columbia, MO
A risk stratification model to predict alloimmunization in sickle cell anemia
Juan Conde, BS, MS, PhD
University of Vermont/Fletcher Allen Health Care
Burlington, VT
Smoking, stroke biomarkers and risk of stroke in a national cohort
Vinay Giri, BS
Duke University Hospital
Durham, NC
Effects of in-home hematopoietic stem cell transplantation on the gut microbiota
Amber Harmon, BS, MPH
University of California (Davis) Health System
Sacramento, CA
RDW in clonal hematopoiesis
Lauren Hawkins, BS
Emory University
Atlanta, GA
A qualitative study of patient and family experience with chronic blood transfusion for sickle cell disease
Cameron Hilton, BA
Cleveland Clinic Foundation
Cleveland, OH
Improving prediction of myelodysplastic syndrome phenotype using advanced analytics
Laura Ibidunni, BS
UPMC Medical Education
Pittsburgh, PA
Beliefs and practices among adults with sickle cell disease regarding reproductive health decisions and family planning
Taylor Linaburg, BS
University of Pennsylvania
Philadelphia, PA
Immune-mediated bone marrow aplasia in patients with Hodgkin lymphoma
Hadrian Mendoza, BS
Yale-New Haven Medical Center
New Haven, CT
Evaluation of positive T- and B-cell gene rearrangement studies in bone marrow among patients without a definitive diagnosis
Kevin Miller, BS
College of Medicine, Mayo Clinic
Rochester, MN
Broadening the scope of BCL-2 inhibition in multiple myeloma
Bryan Nycz, BA
University of Colorado Denver
Denver, CO
Evaluation of microbiome dynamics and infection risk among pediatric patients with acute myelogenous leukemia
Marisa Roman, BA
Medical College of Wisconsin Affiliated Hospitals
Milwaukee, WI
The association between nervous system sensitization and patient-reported outcomes in patients with sickle cell disease
Tolulope Rosanwo, BA
Case Western Reserve University - University Hospitals Case
Cleveland, OH
Modeling sickle cell anemia with induced pluripotent stem cells
Connor Stewart, BS
SUNY Downstate College of Medicine
Brooklyn, NY
Identifying the effects of oncogenic mutations in the nuclear export protein XPO1 in lymphomas
Sang Tran, BA
University of Maryland
Baltimore, MD
Uncovering the anti-leukemic mechanism of artemisinins through the genetic knockdown of MCL-1
WayAnne Watson, BSM
Loma Linda University Medical Center
Loma Linda, CA
Mechanism of biologic therapy to treat high-risk pediatric leukemia

 

Residents:

Recipients Research Topics
Sumedha Arya, MD
University of Toronto
Toronto, Ontario, Canada
Are there inequities in access to care amongst women with inherited bleeding disorders?
Susanna Awoyode, MBBS, MHS
Meharry Medical College
Nashville, TN
Epidemiologic study of premature menopause in women with sickle cell disease
Evan Chen, MD, BA
Brigham and Women's Hospital/Massachusetts General Hospital
Boston, MA
Clinical features and outcomes of patients with myeloid malignancies harboring splicing factor mutations
Sean Clark-Garvey, MD, MPH
Thomas Jefferson University
Philadelphia, PA
Mechanisms of drug-induced apoptosis in diffuse large B-cell lymphoma
Alexander Coltoff, BA, MD
Mount Sinai School of Medicine
New York, NY
Real world outcomes of ruxolitinib for polycythemia vera
Mark Faber, DO
University at Buffalo
Buffalo, NY
Atherosclerotic vascular disease in myelodysplastic syndrome
Amrita Goyal, MD
University of Minnesota
Minneapolis, MN
Increased risk of second primary malignancy in patients with mycosis fungoides
Yang Jiang, MD
University of Texas at Houston/MD Anderson Cancer Center
Houston, TX
Assessing the immune status of patients with chronic myeloid leukemia
Vanessa Kennedy, MD
Stanford University
Stanford, CA
Evaluation of health burden in adolescent and young adult survivors of acute lymphoblastic leukemia
Bindiya Patel, MD
Washington University/B-JH/SLCH Consortium
St. Louis, MO
Frailty in multiple myeloma patients: retrospective study of United States veterans
Matthew Rees, BA, MD
University of Michigan
Ann Arbor, MI
The effect of hemolysis on vaccine response in sickle cell disease
Caner Saygin, MD
Ohio State University Hospital
Columbus, OH
CBL0137 in acute myeloid leukemia
Joy Tang, MD
Medical College of Wisconsin Affiliated Hospitals
Milwaukee, WI
Acute myelogenous leukemia interface with the hematopoietic niche
James Yoon, MD
Emory University
Atlanta, GA
Effect of stem cell boost and donor lymphocyte infusion on the incidence of graft-versus-host disease

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal. 

CONTACT:
Sara Khalaf, American Society of Hematology
skhalaf@hematology.org; 202-552-4925

Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

11 + 7 =

To prevent automated spam submissions leave this field empty.